Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
3.820
-0.575 (-13.08%)
At close: Jul 15, 2025, 4:00 PM
3.890
+0.070 (1.83%)
After-hours: Jul 15, 2025, 4:20 PM EDT
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $165.53 million as of July 15, 2025. Its market cap has decreased by -47.19% in one year.
Market Cap
165.53M
Enterprise Value
-68.02M
1-Year Change
-47.19%
Ranking
Category
Stock Price
$3.82
Market Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $165.53M, a decrease of -81.57%. That is a compound annual growth rate of -69.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2025 | 189.95M | 17.64% |
| Dec 31, 2024 | 161.46M | -82.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |